Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Factors Associated with 18F-Fluorodeoxyglucose Uptake in T1 and T2 Invasive Ductal Carcinoma of the Breast

Factors Associated with 18F-Fluorodeoxyglucose Uptake in T1 and T2 Invasive Ductal Carcinoma of... Purpose The objective of this study was to investigate the in both T1 and T2 breast cancer independently; however, p53 relationship between diversity of F-fluorodeoxyglucose in T1 breast cancer. ( F-FDG) uptake of primary tumor in positron emission to- mography (PET) and various clinicopathologic factors in Keywords F-18 Fluorodeoxyglucose Positron emission . . breast cancer of same pathologic T1, T2 stage. tomography Breast neoplasms TNM staging Methods A total of 258 patients with invasive ductal breast cancer were enrolled in this study. All patients underwent F- FDG PET-CT before surgery. Patients were divided into two Introduction groups according to tumor size based on the pathologic T stage, and maximum standardized uptake value (SUVmax) Breast cancer is the most common malignancy among wom- of 2.5, respectively. en, and the second most frequent cancer overall [1]. In patients Results On the univariate analysis, estrogen receptor (ER), with breast cancer, staging of locally advanced cancer allows tumor size, lymphovascular invasion, p53, pathologic N status appropriate treatment options and offers prognostic informa- (pN) and Nottingham tumor grade (NG) were associated with tion. For this purpose, preoperative F-fluorodeoxyglucose high SUVmax in T1 and T2 breast cancer. On the multivariate ( F-FDG) positron emission tomography-computed http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nuclear Medicine and Molecular Imaging Springer Journals

Factors Associated with 18F-Fluorodeoxyglucose Uptake in T1 and T2 Invasive Ductal Carcinoma of the Breast

Loading next page...
 
/lp/springer-journals/factors-associated-with-18f-fluorodeoxyglucose-uptake-in-t1-and-t2-cAfbSkx0Lg

References (31)

Publisher
Springer Journals
Copyright
Copyright © 2016 by Korean Society of Nuclear Medicine
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1869-3474
eISSN
1869-3482
DOI
10.1007/s13139-016-0409-x
pmid
27540428
Publisher site
See Article on Publisher Site

Abstract

Purpose The objective of this study was to investigate the in both T1 and T2 breast cancer independently; however, p53 relationship between diversity of F-fluorodeoxyglucose in T1 breast cancer. ( F-FDG) uptake of primary tumor in positron emission to- mography (PET) and various clinicopathologic factors in Keywords F-18 Fluorodeoxyglucose Positron emission . . breast cancer of same pathologic T1, T2 stage. tomography Breast neoplasms TNM staging Methods A total of 258 patients with invasive ductal breast cancer were enrolled in this study. All patients underwent F- FDG PET-CT before surgery. Patients were divided into two Introduction groups according to tumor size based on the pathologic T stage, and maximum standardized uptake value (SUVmax) Breast cancer is the most common malignancy among wom- of 2.5, respectively. en, and the second most frequent cancer overall [1]. In patients Results On the univariate analysis, estrogen receptor (ER), with breast cancer, staging of locally advanced cancer allows tumor size, lymphovascular invasion, p53, pathologic N status appropriate treatment options and offers prognostic informa- (pN) and Nottingham tumor grade (NG) were associated with tion. For this purpose, preoperative F-fluorodeoxyglucose high SUVmax in T1 and T2 breast cancer. On the multivariate ( F-FDG) positron emission tomography-computed

Journal

Nuclear Medicine and Molecular ImagingSpringer Journals

Published: Mar 23, 2016

There are no references for this article.